Login / Signup

Double-blinded randomized prospective trial of intranasal capsaicin treatment for nonallergic rhinitis.

Denna ZebdaZi Yang JiangMicah M GibsonChauchau PhamSorour AhmadiSamuel FlorenWilliam C YaoMartin J CitardiAmber U Luong
Published in: International forum of allergy & rhinology (2020)
Using ORM in the objective diagnosis of NAR, this trial showed that intranasal 0.1mM capsaicin not only improved rhinitic symptoms but also objectively reduced nasal reactivity and nasal congestion with a 40% responder rate at 12 weeks as noted by ORM.
Keyphrases
  • phase iii
  • phase ii
  • open label
  • clinical trial
  • study protocol
  • double blind
  • placebo controlled
  • chronic rhinosinusitis
  • physical activity
  • randomized controlled trial
  • gestational age